URIBEL - 0076-0111-01 - (Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate)

Alphabetical Index


Drug Information of URIBEL

Product NDC: 0076-0111
Proprietary Name: URIBEL
Non Proprietary Name: Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
Active Ingredient(s): .12; 120; 10; 36; 40.8    mg/1; mg/1; mg/1; mg/1; mg/1 & nbsp;   Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of URIBEL

Product NDC: 0076-0111
Labeler Name: Star Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20100801

Package Information of URIBEL

Package NDC: 0076-0111-01
Package Description: 100 CAPSULE in 1 BOTTLE (0076-0111-01)

NDC Information of URIBEL

NDC Code 0076-0111-01
Proprietary Name URIBEL
Package Description 100 CAPSULE in 1 BOTTLE (0076-0111-01)
Product NDC 0076-0111
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20100801
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name Star Pharmaceuticals, LLC
Substance Name HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Strength Number .12; 120; 10; 36; 40.8
Strength Unit mg/1; mg/1; mg/1; mg/1; mg/1
Pharmaceutical Classes

Complete Information of URIBEL


General Information